Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality-Reference-Cited by-同舟云学术

Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality

Published:2019-01 Issue: Volume:59 Page:27-33
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Malavasi Vincenzo Livio,Fantecchi Elisa,Gianolio Laura,Pesce Francesca,Longo Giuseppe,Marietta Marco,Cascinu Stefano,Lip Gregory Y.H.,Boriani Giuseppe^ORCID

Publisher

Elsevier BV

Subject

Internal Medicine

Reference47 articles.

1. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention;Albini;J Natl Cancer Inst,2010

2. Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients;Hu;Int J Cardiol,2013

3. Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case-control study;Erichsen;Intern Emerg Med,2012

4. Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey;Lenarczyk;Europace,2017

5. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood,2002

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS);European Heart Journal;2024-08-30

2. Crosslink between atrial fibrillation and cancer: a therapeutic conundrum;Cardio-Oncology;2024-08-07

3. Characteristics and Management of Patients With Cancer and Atrial Fibrillation;JACC: Advances;2024-07

4. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database;Cardiovascular Drugs and Therapy;2024-06-07

5. Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database;Journal of Thrombosis and Thrombolysis;2024-03-20